Reference
Jin K, et al. Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab. Journal of Dermatology 46: e108-e109, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1111/1346-8138.14611 - Japan
Rights and permissions
About this article
Cite this article
Adalimumab/secukinumab. Reactions Weekly 1754, 20 (2019). https://doi.org/10.1007/s40278-019-62253-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-62253-1